Diabetes: RAS inhibition: probably not a one-size-fits-all approach.
Barlovic
Drazenka Pongrac
DP
Cooper
Mark E
ME
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D012084:Renin-Angiotensin System / Q000187:drug effects* / Q000502:physiology*
D000959:Antihypertensive Agents